Company Filing History:
6 out of 1,455 
1 out of 269 
Years Active: 2010-2022
Title: Innovations of Sergei V Kotenko
Introduction
Sergei V Kotenko is a notable inventor based in East Brunswick, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion molecules for therapeutic applications. With a total of 7 patents, Kotenko's work has the potential to impact various medical treatments.
Latest Patents
Kotenko's latest patents include innovative approaches to targeting specific pathological sites. One of his patents focuses on "Phosphatidylserine targeting fusion molecules and methods for their use." This invention involves fusion molecules that combine a cytokine or its portion with a polypeptide, allowing for targeted treatment of diseases responsive to cytokine therapy. Another significant patent is for "Type I and type III interferon fusion molecules and methods for use thereof." This invention describes fusion molecules composed of type I and type III interferon proteins, which can be used to inhibit infections, treat cancer, and induce signaling of transcription of IFN-stimulated genes.
Career Highlights
Throughout his career, Kotenko has worked with reputable institutions such as Rutgers, the State University of New Jersey, and the University of Medicine and Dentistry of New Jersey. His research has contributed to advancements in the understanding and treatment of various diseases.
Collaborations
Kotenko has collaborated with notable individuals in his field, including Grant E Gallagher and Grant F Gallagher. Their combined expertise has likely enhanced the quality and impact of their research endeavors.
Conclusion
Sergei V Kotenko's innovative work in the field of biotechnology showcases his dedication to advancing medical science. His patents reflect a commitment to developing targeted therapies that could improve patient outcomes.